AMC
HEPA

Asset Management Corp’s Hepion Pharmaceuticals HEPA Stock Holding History

Asset Management Corp’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-134
Closed -$204K – 188
2021
Q3 		$204K Buy
134
+42
+46% +$67.2K 0.1% 177
2021
Q2 		$181K Buy
+92
New +$168K 0.1% 167

Other funds holding HEPA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Asset Management Corp's HEPA Position: Q4 2021 in Review

Asset Management Corp sold out of Hepion Pharmaceuticals (HEPA) in Q4 2021, closing a stake of 134 shares — an estimated $204K sold.

Asset Management Corp first reported a position in HEPA in Q2 2021 and held it in 2 quarters. The position peaked at $204K in Q3 2021. 39 funds tracked by Wall St. Rank hold HEPA as of Q4 2021.

  • Asset Management Corp reported no remaining Hepion Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Asset Management Corp sold 134 Hepion Pharmaceuticals shares in Q4 2021, an estimated $204K.
  • Asset Management Corp first reported a position in Hepion Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Asset Management Corp's Hepion Pharmaceuticals position peaked at $204K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q4 2021.

Based on Asset Management Corp's 13F filing for Q4 2021, filed 25 Jan 2022.